SCHEMBL25214950

SCHEMBL25214950

COc1c(C)c(OS(=O)(=O)c2ccc(C)cc2)cc(OS(=O)(=O)c2ccc(C)cc2)c1C(=O)N1Cc2ccc(N)cc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 1/20 0.39
MMP8 P22894 4/20 0.38
MMP3 P08254 2/20 0.38
HSP90AA1 P07900 1/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA7 P43166 2/20 0.38
CA9 Q16790 2/20 0.38
CA14 Q9ULX7 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
GAA P10253 2/20 0.37
CYP1A2 P05177 1/20 0.36
GFER P55789 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25255902 0.87 KCNA1 (0.42) ALDH1A1HPGDHSD17B10CA1CA2
SCHEMBL25212825 0.84 KMT2A (0.41) ALDH1A1HPGDHSD17B10CA1CA2
SCHEMBL30301742 0.83 HSP90AA1 (0.45) ALDH1A1HPGDHSD17B10HSP90AA1MEN1
SCHEMBL25250913 0.79 KMT2A (0.40) ALDH1A1HPGDHSD17B10MEN1KMT2A
SCHEMBL25669111 0.76 ALDH1A1 (0.49) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL30368388 0.76 ALDH1A1 (0.49) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL30368503 0.76 MAPT (0.40) ALDH1A1HPGDSMN1; SMN2LMNAMAPT
SCHEMBL30301793 0.76 MAPT (0.40) ALDH1A1HPGDSMN1; SMN2LMNAMAPT
SCHEMBL30301765 0.75 HSP90AA1 (0.46) ALDH1A1HSP90AA1MEN1KMT2ASMN1; SMN2
SCHEMBL31281629 0.74 NR1H2 (0.41) MMP8MMP3HSP90AA1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240425453-A1 ISOINDOLINES AS PMS2 INHIBITORS CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED (GB) 2024-12-26 US disclosed
EP-4441031-A1 ISOINDOLINES AS PMS2 INHIBITORS Neophore Limited (GB) 2024-10-09 EP disclosed
WO-2023094834-A1 ISOINDOLINES AS PMS2 INHIBITORS Neophore Limited (GB) 2023-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240425453-A1 ISOINDOLINES AS PMS2 INHIBITORS PMS2, MSH2, RECQL ALDH1A1 1114/4885HPGD 991/4885HSD17B10 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.